Angelos Liontos Author
Subjects of specialization
Affiliation
COVID-19, Ketoacidosis, SARS-COV-2
Department of Infectious Diseases, University Hospital of Ioannina, Ioannina, Greece
Angelos Liontos Department of Infectious Diseases, University Hospital of Ioannina, Ioannina, Greece. His publications include: 1.Zheng, Z., et al., Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis. J Infect, 2020. 81(2): p. e16-e25. 2.Jordan, R.E., P. Adab, and K.K. Cheng, Covid-19: risk factors for severe disease and death. Bmj, 2020. 368: p. m1198. 3.Wei, Y., et al., Clinical characteristics and outcomes of patients with diabetic ketoacidosis of different severity. Medicine (Baltimore), 2020. 99(45): p. e22838.
Case Report Open Access
Author(s): Sempastian Filippas-Ntekouan, Angelos Liontos, Fotios Barkas, Theodora Maniatopoulou, Revekka Konstantopoulou, Theodora Dimitriou, Georgia Manthou and Haralampos Milionis
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infections have affected millions of persons around the globe since first described in December 2019. Coronavirus Disease (COVID-19) is primarily a respiratory tract infection and in severe cases may lead to pneumonia, acute respiratory distress syndrome and death. Diabetes mellitus comprises a serious comorbidity that has been associated with increased risk of adverse outcomes. In these patients, COVID-19 has been associated with increased risk of ketosis and ketoacidosis which is a life-threatening complication. Herein, we describe a case of a SARS-CoV-2 positive patient presenting with symptomatic euglycemic ketoacidosis soon after the initiation of a Sodium-Glucose Co-Transporter-2 (SGLT-2) inhibitor. Clinicians should be ... view moreĀ»